Legato Capital Management LLC Xeris Biopharma Holdings, Inc. Transaction History
Legato Capital Management LLC
- $703 Million
- Q1 2025
A detailed history of Legato Capital Management LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 217,318 shares of XERS stock, worth $1.07 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
217,318
Previous 142,164
52.86%
Holding current value
$1.07 Million
Previous $481,000
148.02%
% of portfolio
0.17%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
203Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$50.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$39.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$21.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$16.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $669M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...